Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells

Science(2021)10.1126/science.abj9853Source: DataRank Database

Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells is a research paper published in Science (2021). On theSindex it has a DataRank of 0. It has been cited 354 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access354 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 18.77)OA: greenTopics (78)Linked Datasets (16)DataCite Reuse (16)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Jennifer M. Dan ORCID,Zeli Zhang ORCID,Carolyn Rydyznski Moderbacher ORCID,Marshall Lammers ORCID,Benjamin Goodwin ORCID

Live enrichment

PubMed:34519540 PMC:PMC8542617 OpenAlex:https://openalex.org/W3199923482

NIAID NIH HHS

Grant: HHSN272201500002C

NIAID NIH HHS

Grant: R25 AI147376

NIH HHS

Grant: P51 OD011132

NIAID NIH HHS

Grant: K08 AI135078

NIAID NIH HHS

Grant: U01 AI149644

NIAID NIH HHS

Grant: UM1 AI148373

NIAID NIH HHS

Grant: UM1 AI148684

NIAID NIH HHS

Grant: R01 AI135193

NIAID NIH HHS

Grant: U19 AI142742

NIAID NIH HHS

Grant: UM1 AI148576

National Institutes of Health

Grant: 5K08AI135078-02

The Immunology of Recurrent Group A Streptococcus Tonsillitis

National Institutes of Health

Grant: 5UM1AI148576-02

Vaccine and Treatment Evaluation Units

National Institutes of Health

Grant: 3UM1AI148373-02S1

Kaiser Washington Vaccine and Treatment Evaluation Unit

National Institutes of Health

Grant: 1U01AI149644-01

Respiratory Virus Vaccine and Adjuvant Exploration

National Institutes of Health

Grant: 3P51OD011132-64S2

Renovation to expand and enhance NHP housing for HIV/AIDS research at the Emory NPRC

National Institutes of Health

Grant: 5U19AI142742-03

Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses

National Institutes of Health

Grant: 3UM1AI148684-03S1

Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)

FWCI

18.77

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: cc-by

repositoryhttp://europepmc.org/pmc/articles/PMC8542617

publisherhttps://www.science.org/doi/pdf/10.1126/science.abj9853

journalhttps://doi.org/10.1126/science.abj9853

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34519540

Fields of Study

SARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesVaccine Coverage and Hesitancy0301 basic medicine03 medical and health sciences2019-nCoV Vaccine mRNA-1273AdolescentAdultAgedAged, 80 and overAntibodies, ViralCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCOVID-19COVID-19 VaccinesClinical Trials, Phase I as TopicCross ReactionsHumansImmunogenicity, VaccineImmunologic MemoryMiddle AgedSpike Glycoprotein, CoronavirusVaccinationYoung Adult

MeSH Terms

Immunogenicity, VaccineCOVID-19COVID-19 Vaccines2019-nCoV Vaccine mRNA-1273AdolescentAdultAgedAged, 80 and overAntibodies, ViralCross ReactionsHumansImmunologic MemoryMiddle AgedVaccinationCD4-Positive T-LymphocytesClinical Trials, Phase I as TopicCD8-Positive T-LymphocytesYoung AdultSpike Glycoprotein, Coronavirus

Keywords

VaccinationMessenger RNAImmune systemCoronavirus disease 2019 (COVID-19)MedicineImmunologyVirologyImmunityAntibodyClinical trialSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyInternal medicineDiseaseGeneInfectious disease (medical specialty)AdultAged, 80 and overCD4-Positive T-LymphocytesCOVID-19 VaccinesAdolescentClinical Trials, Phase I as TopicCOVID-19CD8-Positive T-LymphocytesCross ReactionsMiddle AgedAntibodies, ViralYoung AdultImmunogenicity, VaccineSpike Glycoprotein, CoronavirusHumansImmunologic MemoryResearch Articles2019-nCoV Vaccine mRNA-1273Aged

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine

10.6084/m9.figshare.19766535.v1figshare

Additional file 1 of MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine

10.6084/m9.figshare.19766535figshare

Additional file 1 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study

10.6084/m9.figshare.21532813.v1figshare

10.6084/m9.figshare.21532813figshare

Additional file 2 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study

10.6084/m9.figshare.21532816.v1figshare

10.6084/m9.figshare.21532816figshare

Additional file 3 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study

10.6084/m9.figshare.21532819.v1figshare

10.6084/m9.figshare.21532819figshare

Additional file 4 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study

10.6084/m9.figshare.21532822.v1figshare

10.6084/m9.figshare.21532822figshare

Additional file 5 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study

10.6084/m9.figshare.21532825.v1figshare

10.6084/m9.figshare.21532825figshare

Additional file 6 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study

10.6084/m9.figshare.21532828.v1figshare

10.6084/m9.figshare.21532828figshare

Additional file 7 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study

10.6084/m9.figshare.21532831figshare

10.6084/m9.figshare.21532831.v1figshare